{"result": "(\"entity\"<|>GRUPO ANDALUZ DE NUTRICIÓN E INVESTIGACIÓN<|>ORGANIZATION<|>The Andalusian Group of Nutrition and Research is an organization that publishes recommendations regarding blood glucose monitoring and management in patients starting artificial nutrition.)\n##\n(\"entity\"<|>GLUCEMIA CAPILAR<|>EVENT<|>Capillary blood glucose monitoring is a procedure recommended for patients starting artificial nutrition to manage their blood sugar levels effectively.)\n##\n(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a chronic condition that affects how the body processes blood sugar (glucose), requiring careful management of nutrition and insulin therapy.)\n##\n(\"entity\"<|>INSULINOTERAPIA<|>EVENT<|>Insulin therapy is a treatment for diabetes that involves administering insulin to control blood sugar levels, particularly in patients requiring nutritional support.)\n##\n(\"entity\"<|>HIPERGLUCEMIA<|>EVENT<|>Hyperglycemia is a condition characterized by an excessive amount of glucose in the blood, often requiring intervention in patients with diabetes.)\n##\n(\"entity\"<|>HIPOGLUCEMIA<|>EVENT<|>Hypoglycemia is a condition where blood sugar levels drop too low, which can occur in patients receiving insulin therapy and requires careful monitoring.)\n##\n(\"entity\"<|>SODIO<|>EVENT<|>Sodium is an essential electrolyte that must be monitored and managed in patients with short bowel syndrome to prevent complications.)\n##\n(\"entity\"<|>ELECTROLITOS<|>EVENT<|>Electrolytes are minerals in the body that carry an electric charge and are crucial for various bodily functions, requiring careful management in patients with short bowel syndrome.)\n##\n(\"relationship\"<|>GRUPO ANDALUZ DE NUTRICIÓN E INVESTIGACIÓN<|>ESPEN<|>The Andalusian Group of Nutrition and Research aligns with ESPEN's guidelines for managing patients requiring nutritional support<|>6)\n##\n(\"relationship\"<|>PACIENTE<|>DIABETES<|>The patient has diabetes, which complicates their nutritional management and requires specific guidelines for insulin therapy<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>HIPERGLUCEMIA<|>The patient experiences hyperglycemia, necessitating careful monitoring and management of their blood glucose levels<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>HIPOGLUCEMIA<|>The patient is at risk of hypoglycemia due to insulin therapy, requiring close monitoring of their blood sugar levels<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>SODIO<|>The patient requires management of sodium levels due to their condition, which can lead to complications if not properly monitored<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>ELECTROLITOS<|>The patient needs careful management of electrolytes to maintain health and prevent complications associated with short bowel syndrome<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>INSULINOTERAPIA<|>Insulin therapy is often required in conjunction with parenteral nutrition to manage blood glucose levels in patients<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: (113-\n     160 mg/dl), aunque aquejan falta de protocolos estandarizados2 .\n              Es en 2013, cuando la ASPEN publica las recomendaciones y objetivos de gluce-\n     mia en pacientes que reciben soporte nutricional3 ; así como la Endocrine Society\n     Clinical Practice Guideline sugiere iniciar terapia insulínica en pacientes con diabetes\n\n\n\n132\n---\nno conocida previamente que presentan hiperglucemia > 140 mg/dl de forma persis-\ntente4 .\n         En un artículo publicado recientemente por el Grupo Andaluz de Nutrición e\nInvestigación se recomienda realizar glucemia capilar c/6-8h hasta 24 h en pacientes\nque inician nutrición artificial; si < 140 mg/dl, aconsejan reducir el número controles\nsegún situación y si > 140 mg/dl ajustar en función de pauta insulínica. Estos autores\nadvierten que los protocolos de perfusión continua de insulina deben diseñarse de\nforma que eviten valores estrictos de glucemia (80-110 mg/dl) para disminuir riesgo de\nhipoglucemia5 .\n         Nuestra paciente presenta un síndrome de intestino corto (SIC), dado que\npreserva < 115 cm de ID finalizado en yeyunostomía terminal. En sus últimas guías, la\nESPEN, establece la diferencia entre deficiencia intestinal y fallo o fracaso intestinal,\nprecisando éste último “la suplementación intravenosa para mantener la salud y/o\ncrecimiento”6 .\n         Existen distintos estadíos clínicos en el SIC. En la fase aguda se objetivan grandes\npérdidas de agua y electrolitos así como una hipersecreción gástrica.\n\n\n\n         En una yeyunostomía la pérdida de sodio es de 90 mEq/L, provocando un hipe-\nraldosteronismo secundario que deberemos tratar adecuadamente con el objetivo de\nmantener un Na orina > 20 mmol/L.\n\n\n\n         En cuanto al manejo del fallo intestinal agudo, tanto las guías americanas como\neuropeas, coinciden en mantener el estado nutricional, corregir las alteraciones\nhidroelectrolíticas y mejorar la calidad de vida como objetivos principales.\n\n\n\n         La ESPEN recomienda asegurar estabilidad hemodinámica mediante agua y elec-\ntrolitos iv (SS 0,9% 1-4 L/d según pérdidas), siendo obligatoria en la fase hipersecretora\nla NP durante los primeros 7-10 días, pero no necesariamente de forma exclusiva7  .\n\n\n\n         La ASPEN establece que lo prioritario es estabilizar al paciente incluyendo el\ndesequilibrio electrolítico y posteriormente iniciar soporte nutricional, siendo la NP la\nforma más adecuada en pacientes con diarrea severa8 .\n         En cuanto al tipo de fórmula de la NP, la ESPEN recomienda el cálculo de re-\nquerimientos habitual con reparto de macronutrientes estándar. No precisa nutrientes\nespecíficos y la suplementación con GH, glutamina o GLP2 no está recomendado7 .\n\n\n\n         Respecto a las fórmulas de NP en pacientes con DM se recomienda un cálculo de\nmacronutrientes igual que en no DM, considerando un aporte mínimo de glucosa entre\n100-150 g/día para evitar cetosis y no sobrepasar 1.3 g/kg/día de lípidos. El uso de\n\n\n\n                                                                                               133\n---\n     glutamina o el tipo de grasa (oleico y omega 3) podrían mejorar el control glucémico,\n     pero no existe suficiente evidencia científica actual y los resultados no son concluyentes 9.\n\n\n\n              Tampoco existen estudios randomizados que comparen distintos regímenes de\n     insulinoterapia en pacientes portadores de NP, utilizando en la práctica habitual I.\n     Regular intrabolsa + pauta correctora sc c/6-8h 10.\n\n\n\n              Es en la fase de adaptación donde podemos iniciar la transición de NP a NE/oral,\n     teniendo en cuenta que el 70% de SIC precisan nutrición parenteral domiciliaria (NPD)\n     al alta y la dependencia de NP a 1,2 y 5 años es del 74%, 64% y 48% respectivamente 6.\n\n\n\n              La ESPEN establece que en fase de adaptación la NE debe iniciarse de forma\n     precoz, incluso de forma combinada con la NP cuando las pérdidas digestivas sean\n     < 2.5 L/d. Se demuestra que en pequeñas cantidades mejora la adaptación intestinal y\n     la perfusión continua se tolera mejor que en bolos.\n\n\n\n              En cuanto al tipo de fórmula de la NE, el uso de glutamina, GH y fórmulas espe-\n     ciales no está recomendado por resultados no concluyentes7 .\n\n\n\n              La ASPEN propone el uso de fórmulas poliméricas que generalmente son bien\n     toleradas, aunque en ocasiones puede precisarse de una fórmula semielemental; reser-\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ASPEN<|>ORGANIZATION<|>ASPEN is an organization that publishes guidelines and recommendations for nutritional support in patients, particularly those with diabetes and other conditions requiring specialized care.)\n##\n(\"entity\"<|>ESPEN<|>ORGANIZATION<|>ESPEN is an organization that provides guidelines for clinical nutrition and the management of patients requiring nutritional support, including those with short bowel syndrome.)\n##\n(\"entity\"<|>SINDROME DE INTESTINO CORTO<|>EVENT<|>Short bowel syndrome (SIC) is a medical condition characterized by the malabsorption of nutrients due to the surgical removal of a significant portion of the intestine.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL<|>EVENT<|>Parenteral nutrition (NP) is a method of feeding that bypasses the gastrointestinal tract, providing nutrients directly into the bloodstream, often used for patients with severe digestive issues.)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL<|>EVENT<|>Enteral nutrition (NE) is a method of feeding that delivers nutrients directly into the stomach or intestine, typically used when patients can still digest food but require additional support.)\n##\n(\"entity\"<|>PACIENTE<|>PERSON<|>The patient referred to in the text is someone suffering from short bowel syndrome and requiring nutritional support.)\n##\n(\"relationship\"<|>PACIENTE<|>SINDROME DE INTESTINO CORTO<|>The patient is diagnosed with short bowel syndrome, which affects their nutritional needs and management<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>NUTRICIÓN PARENTERAL<|>The patient requires parenteral nutrition due to their condition, which necessitates bypassing the gastrointestinal tract<|>9)\n##\n(\"relationship\"<|>PACIENTE<|>NUTRICIÓN ENTERAL<|>The patient may transition to enteral nutrition as part of their recovery and adaptation process<|>6)\n##\n(\"relationship\"<|>ASPEN<|>ESPEN<|>Both ASPEN and ESPEN are organizations that provide guidelines for nutritional support in patients, indicating a collaborative or complementary relationship<|>7)\n<|COMPLETE|>"}]}